Elixir International
This article was originally published in The Rose Sheet
Executive Summary
A "200-page Vogue-style magazine" and "the first quarterly consumer glossy to target the huge interest in anti-aging products and services," Elixir International will launch in UK and internationally in October for $7, according to Aug. 24 announcement. Targeted to men and women over the age of 28, magazine will be distributed free to spas, cruise ships, luxury hotels, gyms, airport business lounges and private charter jets, and it will be available online to meet demand of Internet readers and advertisers, Elite Publishing of London notes. "If it's hot, new and will improve your lifespan ... you will find out about it" in Elixir International, publisher says. Coverage will encompass anti-aging cosmetics, nutraceuticals, cosmeceuticals, diet and exercise, cosmetic surgery, cosmetic dentistry and spas, but anti-aging lifestyle "may also be reflected by your home, its décor and even the type of car that you drive and the way you dress," Elite says. Magazine's medical panel includes Dr. Bob Goldman, chairman of the American Academy of Anti-Aging Medicine, cosmetic surgeon Javier de Benito and Dr. Nicholas Perricone, creator of skin-care brand PerriconeMD (1"The Rose Sheet" April 7, 2008, p. 8)
You may also be interested in...
PerriconeMD Overhauls Skin-Care Line For Independent, Informed Consumers
PerriconeMD Cosmeceuticals has repackaged and repositioned its skin-care line to cater to increasingly knowledgeable consumers and "improve both the purchase and user experience.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.